AQUESTIVE THERAPEUTICS INC. - COMMON STOCK
4.5700
14-November-24 16:45:00
15 minutes delayed
Stocks
-0.2600
-5.38%
Today's range
4.5200 - 4.8600
ISIN
N/A
Source
NASDAQ
-
Aquestive Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
01 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Licenses Sympazan® (clobazam) Oral Film to Assertio Holdings, Inc.
27 Oct 2022 09:05:24 By Nasdaq GlobeNewswire
-
24 Oct 2022 08:00:00 By Nasdaq GlobeNewswire
-
19 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
11 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
28 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
27 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board
12 Sep 2022 16:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Investor Conferences in September
31 Aug 2022 16:02:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Receives FDA Tentative Approval for Libervant™ (diazepam) Buccal Film
31 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space
10 Aug 2022 16:50:35 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
02 Aug 2022 16:02:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Wedbush PacGrow Healthcare Conference
26 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
20 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
11 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
15 Jun 2022 16:22:33 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics, Inc. Announces Closing of $8.5 Million Registered Direct Offering
08 Jun 2022 16:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in JMP Securities Life Sciences Conference
07 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
06 Jun 2022 08:30:00 By Nasdaq GlobeNewswire